| Literature DB >> 31349556 |
Stefania Garzoli1, Giovanni Turchetti2, Pierluigi Giacomello3, Antonio Tiezzi2, Valentina Laghezza Masci2, Elisa Ovidi4.
Abstract
Essential oils from Lavandula genus and the obtained hybrids are widely used for different purposes such as perfume production in the cosmetic field and for its biological properties. This is the first study on the liquid and vapour phase of Lavandula × intermedia "Grosso" essential oil grown in the Lazio Region, Italy, investigated using headspace coupled to gas chromatography and mass spectrometry (HS-GC/MS). The results showed the most abundant components were linalool and linalyl acetate, followed by 1,8-cineole and terpinen-4-ol, while lavandulyl acetate and borneol were identified as minor compounds, maintaining the same proportion in both the liquid and vapour phase. Furthermore, we tested lavandin liquid and vapour phase essential oil on gram-negative bacteria (Escherichia coli, Acinetobacter bohemicus, and Pseudomonas fluorescens) and gram-positive bacteria (Bacillus cereus and Kocuria marina).Entities:
Keywords: HS-GC/MS analysis; antibacterial activity; lavandin essential oil; liquid phase; vapour phase
Year: 2019 PMID: 31349556 PMCID: PMC6696025 DOI: 10.3390/molecules24152701
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Chemical composition (%) of Lavandula × intermedia cv. “Grosso” essential oil (LEO).
| No. | Component 1 | LRIlit 2 | LRI 3 | LRI 4 | GC Peak Area (%) | HS-GC Peak Area (%) |
|---|---|---|---|---|---|---|
| 1 | α-pinene | 1021 | 1019 | 935 | 1.1 | 8.7 |
| 2 | camphene | 1065 | 1055 | 946 | 0.5 | 3.7 |
| 3 | β-pinene | 1105 | 1100 | 981 | 0.4 | 2.8 |
| 4 | myrcene | 1156 | 1152 | 984 | 1.5 | 4.9 |
| 5 | α-phellandrene | 1160 | 1161 | 999 | 0.1 | 0.7 |
| 6 | limonene | 1198 | 1195 | 1025 | 1.0 | 3.5 |
| 7 | 1,8-cineole | 1209 | 1210 | 1028 | 5.2 | 19.8 |
| 8 | ( | 1237 | 1231 | 1038 | 0.9 | - |
| 9 | γ-terpinene | 1241 | 1235 | 1046 | 0.2 | - |
| 10 | trans-β-ocimene | 1276 | 1275 | 1055 | 0.7 | - |
| 11 | terpinolene | 1282 | 1283 | 1072 | 0.4 | - |
| 12 | o-cymene | 1287 | 1290 | 1025 | 0.2 | 1.7 |
| 13 | hexyl isobutyrate | 1335 | 1333 | 1145 | 0.3 | - |
| 14 | 1-octen-3-yl-acetate | 1401.9 | 1400 | 1122 | 0.5 | 0.7 |
| 15 | hexyl butanoate | 1410 | 1414 | 1177 | 0.5 | - |
| 16 | 1-octen-3-ol | 1458 | 1461 | 970 | 0.3 | 0.4 |
| 17 | camphor | 1507 | 1500 | 1133 | 6.0 | 4.4 |
| 18 | linalool | 1537 | 1539 | 1092 | 41.6 | 35.8 |
| 19 | linalyl acetate | 1553 | 1549 | 1245 | 23.0 | 7.5 |
| 20 | lavandulyl acetate | 1584 | 1580 | 1265 | 3.2 | 0.8 |
| 21 | terpinen-4-ol | 1603 | 1600 | 1174 | 4.8 | 2.9 |
| 22 | ( | 1613 | 1615 | 1428 | 1.3 | - |
| 23 | ( | 1630 | 1635 | 1445 | 1.3 | - |
| 24 | α-terpineol | 1675 | 1680 | 1185 | 1.6 | 0.4 |
| 25 | γ-muurolene | 1685 | 1687 | 1508 | 0.5 | - |
| 26 | borneol | 1717 | 1721 | 1158 | 2.8 | 1.2 |
| Total (%) | 99.9 | 99.9 | ||||
| Monoterpenoids | 89.2 | 94.4 | ||||
| Sesquiterpenoids | 3.1 | - | ||||
| Others | 7.6 | 5.5 |
1 Elution order on polar column; 2 Linear retention indices from literature; 3 Linear retention indices measured on polar column; 4 Linear retention indices measured on apolar column. HS-GC: Headspace coupled to gas chromatography.
Percentage of the main compounds in the LEO sample in comparison with the accepted percentages by European Pharmacopoeia (EPh).
| Component | EPh | Lavandin |
|---|---|---|
| linalool | 25–45 | 41.6 |
| linalyl acetate | 25–46 | 23.0 |
| 1,8-cineole | max. 2.5 | 5.2 |
| camphor | 12–18 | 6.0 |
Growth inhibition halo (mm) for LEO and the positive control (gentamicin) against the five tested Gram+ and Gram− bacterial strains (p values ≤ 0.05).
| Agar Diffusion Test | LEO (10 µL) | Gen (20 µg) | |
|---|---|---|---|
|
| halo ± SD (mm) | halo ± SD (mm) | |
|
|
| 13.0 ± 1.41 | 16.5 ± 2.12 |
|
| 47.0 ± 4.24 | 34.5 ± 0.70 | |
|
| 8.5 ± 0.70 | 25.5 ± 0.70 | |
|
|
| 21.5 ± 0.70 | 28.5 ± 0.70 |
|
| 14.5 ± 2.12 | 27.0 ± 2.83 |
Minimum inhibitory concentration (MIC) and Minimum bactericidal concentration (MBC) means for LEO expressed in percentage values (%) and the positive control (gentamicin) expressed in µg/mL against the five tested bacterial strains.
| Microdilution Test | LEO | Gen | |||
|---|---|---|---|---|---|
| Strain | MIC (%Mean) | MBC (%Mean) | MIC (µg/mLMean) | MBC (µg/mLMean) | |
|
|
| 1.87 | 1.87 | 3.12 | 6.25 |
|
| 0.47 | 0.47 | 0.08 | 0.31 | |
|
| 3.75 | 7.51 | 1.56 | 6.25 | |
|
|
| 0.94 | Bacteriostatic | 1.56 | 3.12 |
|
| 1.87 | Bacteriostatic | 0.39 | 1.56 | |
LEO vapour phase test showing minimum inhibitory concentration (MIC) and minimum bactericidal concentration means (MBC) expressed in µL against the five bacteria tested.
| LEO VPT (Vapour Phase Test) | |||
|---|---|---|---|
| Strain | MIC (µL Mean) | * MBC (µL Mean) | |
|
|
| 20 | 40 |
|
| <2 | 20 | |
|
| >40 | >40 | |
|
|
| 20 | 20 |
|
| 20 | 40 | |
* After seven days.
Figure 1Representative image showing antibacterial activity against a bacterial strain.